RECCHIA, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.011
EU - Europa 4.710
AS - Asia 4.612
SA - Sud America 677
Continente sconosciuto - Info sul continente non disponibili 275
AF - Africa 106
OC - Oceania 57
Totale 21.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.778
IT - Italia 1.487
SG - Singapore 1.446
GB - Regno Unito 1.167
CN - Cina 1.156
VN - Vietnam 520
HK - Hong Kong 513
BR - Brasile 505
SE - Svezia 501
DE - Germania 356
BD - Bangladesh 225
FR - Francia 224
RU - Federazione Russa 203
FI - Finlandia 170
UA - Ucraina 166
TR - Turchia 113
CA - Canada 110
KR - Corea 107
IN - India 99
ID - Indonesia 84
NL - Olanda 83
JP - Giappone 65
MX - Messico 61
BG - Bulgaria 60
AR - Argentina 57
BE - Belgio 51
IQ - Iraq 48
AU - Australia 47
ZA - Sudafrica 44
AE - Emirati Arabi Uniti 34
IE - Irlanda 33
LT - Lituania 31
BZ - Belize 28
ES - Italia 27
PK - Pakistan 27
CO - Colombia 26
EC - Ecuador 22
MY - Malesia 21
VE - Venezuela 21
PL - Polonia 20
AT - Austria 19
IR - Iran 19
PH - Filippine 17
CH - Svizzera 16
CL - Cile 16
CZ - Repubblica Ceca 16
JO - Giordania 16
SA - Arabia Saudita 16
MA - Marocco 15
UZ - Uzbekistan 12
NP - Nepal 11
AL - Albania 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
PT - Portogallo 9
SI - Slovenia 9
TH - Thailandia 9
LU - Lussemburgo 8
PE - Perù 8
RO - Romania 8
BO - Bolivia 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
RS - Serbia 7
UY - Uruguay 7
GR - Grecia 6
TW - Taiwan 6
AZ - Azerbaigian 5
BY - Bielorussia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
IL - Israele 5
JM - Giamaica 5
PS - Palestinian Territory 5
ET - Etiopia 4
KZ - Kazakistan 4
NG - Nigeria 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
QA - Qatar 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
PR - Porto Rico 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BW - Botswana 2
CY - Cipro 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
Totale 21.158
Salva come PNG Salva come JPEG
Città #
Ashburn 1.065
Fairfield 1.041
Singapore 978
Santa Clara 934
Southend 746
Chandler 598
Woodbridge 586
San Jose 506
Houston 500
Hong Kong 490
Seattle 384
Cambridge 362
Ann Arbor 336
Wilmington 320
Jacksonville 301
Dearborn 279
Nyköping 274
Hefei 262
Beijing 242
Modena 213
Los Angeles 208
Council Bluffs 197
London 186
Chicago 182
New York 150
Ho Chi Minh City 142
Bologna 127
Helsinki 125
Hanoi 120
The Dalles 105
San Diego 102
Seoul 92
Milan 79
Buffalo 75
Princeton 73
Moscow 65
Jakarta 63
Salt Lake City 63
Lauterbourg 59
Sofia 59
Dallas 56
Bremen 55
Eugene 52
Brussels 49
Izmir 48
Rome 48
Shanghai 48
Elk Grove Village 40
Orem 40
Munich 39
São Paulo 39
Frankfurt am Main 36
Toronto 36
Phoenix 34
Columbus 33
Tampa 33
Da Nang 32
Redwood City 32
Des Moines 30
Falls Church 30
Belize City 28
San Francisco 28
Parma 27
Tokyo 27
Dublin 26
Dong Ket 25
Haiphong 25
Paris 24
Boardman 23
Brooklyn 23
Las Vegas 23
Bari 22
Mexico City 22
Atlanta 21
Montreal 20
Rio de Janeiro 20
Boydton 19
Mumbai 19
Baghdad 18
Boston 18
Naples 18
Turin 18
Amsterdam 17
Chennai 17
Johannesburg 17
Lancaster 17
Denver 16
Trieste 16
Warsaw 16
Guangzhou 15
Nuremberg 15
Sterling 15
Stockholm 15
Biên Hòa 14
Poplar 14
Wuhan 14
Albuquerque 13
Fremont 13
Nanjing 13
Portsmouth 13
Totale 14.263
Salva come PNG Salva come JPEG
Nome #
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 590
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 457
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 436
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 434
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 432
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 427
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 426
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 422
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 412
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 405
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 397
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 383
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 380
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 370
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 369
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 364
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 364
Comprehensive genomic access to vector integration in clinical gene therapy 359
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 358
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 340
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 338
Nuclear architecture dictates HIV-1 integration site selection 336
Site-specific integration by the adeno-associated virus rep protein 332
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 329
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 324
Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone 324
A single epidermal stem cell strategy for safe ex vivo gene therapy 321
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 320
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy 312
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 310
AAV-CRISPR Persistence in the Eye of the Beholder 308
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 302
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 296
Site-specific integration into the human genome: Ready for clinical application? 294
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 294
Tracking gene-modified T cells in vivo. 290
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 288
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 286
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 280
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 279
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 275
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 275
Defining the lentiviral integrome in human hematopoietic cells 270
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector 262
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 255
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells 250
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 250
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 250
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector 248
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 243
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration 237
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination 237
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 237
Gene editing prospects for treating inherited retinal diseases 225
Targeted integration of a large transgene cassette by TALEN and ZFN-mediated homologous recombination. 224
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 222
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 220
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 213
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisâ acting DNA elements that govern muscle dystrophin expression 204
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 183
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 182
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 173
Corrigendum to: “Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression”. [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138–1147.] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017) 1860(11) (1138–1147), (S1874939917301359), (10.1016/j.bbagrm.2017.08.010)) 168
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 167
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 163
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 160
Collagen VII gene delivery via an Adeno-Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 157
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 155
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 154
The Journal of Gene Medicine European Society of Gene Therapy Young Investigator Award 2004 145
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 143
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 141
TALEN-mediated in situ correction of a genetic defect by homologous recombination into the native locus 140
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 136
Engineered nucleases-mediated in situ correction of a genetic defect by homologous recombination into the native locus 135
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 61
Totale 21.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.679 0 173 208 102 113 101 132 123 145 112 279 191
2022/20231.921 211 207 165 218 243 257 50 160 207 25 96 82
2023/20241.186 53 72 93 99 217 70 113 147 28 84 83 127
2024/20253.502 105 46 131 229 664 517 274 251 355 184 341 405
2025/20266.637 419 221 428 737 1.242 425 755 258 674 641 473 364
2026/2027234 221 13 0 0 0 0 0 0 0 0 0 0
Totale 21.448